ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Tyk2

Tyk2

概要

Name:Tyrosine-protein kinase 2
Target Synonym:EC:2.7.10.2,TYK2,Tyrosine Kinase 2,Non-Receptor Tyrosine-Protein Kinase TYK2,EC 2.7.10.2,IMD35,JTK1,TYK2 Kinase,EC 2.7.10
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
TY2-H5547 Human Human Tyk2 Protein, His Tag (active enzyme)
TY2-H5547-structure
TY2-H5548 Human Human Tyk2 Protein, His Tag
TY2-H5548-structure
TY2-H5548-sds
ACRO Quality

Synonym Name

Tyk2,tyrosine kinase 2

Background

Tyk2 was the first member of the JAK family that was described (the other members are JAK1, JAK2, and JAK3). It has been implicated in IFN-?, IL-6, IL-10 and IL-12 signaling. Tyk2 functions primarily in IL-12 and type I-IFN signaling. Tyk2 deficiency has more dramatic effects in human cells than in mouse cells. However, in addition to IFN-? and -? and IL-12 signaling, Tyk2 has major effects on the transduction of IL-23, IL-10, and IL-6 signals. Recently, it has been recognized that IL-12 and IL-23 share ligand and receptor subunits that activate Tyk2. Tyk2 is activated by IL-10, and its deficiency affects the ability to generate and respond to IL-10.

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Peficitinib ASP-015K; JNJ-54781532 Approved Astellas Pharma Inc Smyraf Japan Arthritis, Rheumatoid Astellas Pharma Inc 2019-03-29 Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative Details
Deucravacitinib BMS-986165; BMS-986165-01 Approved Bristol-Myers Squibb Company Sotyktu Japan Psoriasis Bristol-Myers Squibb Kk 2022-09-09 Lupus Vulgaris; Inflammatory Bowel Diseases; Alopecia Areata; Lupus Erythematosus, Discoid; Autoimmune Diseases; Lupus Erythematosus, Cutaneous; Lupus Nephritis; Liver Diseases; Psoriasis; Lupus Erythematosus, Systemic; Colitis, Ulcerative; Arthritis, Psoriatic; Inflammation; Crohn Disease; Plaque psoriasis Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
ABBV-712 ABBV-712 Phase 1 Clinical Abbvie Inc Psoriasis Details
MAX-40070 MAX-40070 Phase 1 Clinical Maxinovel Pty Ltd Alopecia Areata Details
GLPG-3121 GLPG-3121 Phase 1 Clinical Galapagos Nv Details
BGB-23339 BGB-23339 Phase 1 Clinical Beigene Ltd Autoimmune Diseases; Plaque psoriasis Details
OST-122 OST-122 Phase 2 Clinical Oncostellae Sl Colitis, Ulcerative Details
TLL-018 TLL-018 Phase 2 Clinical Tll Pharmaceutical Llc Chronic Urticaria; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Urticaria Details
TQ-05105 TQ-05105 Phase 2 Clinical Lianyungang Runzhong Pharmaceutical Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Centaurus Biopharma Co Ltd Myeloproliferative Disorders; Neoplasms; Graft vs Host Disease; Primary Myelofibrosis; Lymphohistiocytosis, Hemophagocytic Details
ICP-488 ICP-488 Phase 1 Clinical InnoCare Pharma Ltd Autoimmune Diseases; Psoriasis; Plaque psoriasis Details
ESK-001 ESK-001 Phase 2 Clinical Alumis Inc Autoimmune Diseases; Psoriasis Details
QY201 QY-201; QY201 Phase 2 Clinical E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd Alopecia Areata; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Dermatitis, Atopic Details
ICP-332 ICP-332 Phase 1 Clinical InnoCare Pharma Ltd Psoriasis; Dermatitis, Atopic Details
Brepocitinib PF-06700841-15; PF-6700841; PF-841; PF-06700841 Phase 3 Clinical Pfizer Inc Alopecia; Alopecia Areata; Dermatomyositis; Kidney Diseases; Lupus Erythematosus, Systemic; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Dermatitis, Atopic; Vitiligo; Crohn Disease Details
Ropsacitinib PF-06826647 Phase 2 Clinical Pfizer Pharmaceuticals Ltd (China) Psoriasis; Colitis, Ulcerative; Hidradenitis Suppurativa Details
VTX-958 VTX-958 Phase 2 Clinical Ventyx Biosciences Inc Plaque psoriasis Details
NDI-034858 NDI-034858 Phase 2 Clinical Nimbus Therapeutics LLC Psoriasis; Arthritis, Psoriatic; Plaque psoriasis Details
GLPG-3667 GLPG-3667 Phase 1 Clinical Galapagos Nv Psoriasis Details

This web search service is supported by Google Inc.

totopphone